血液温度インジケータの世界市場：温度範囲、用途、エンドユーザー別-2025～2030年予測

血液温度インジケータ市場は、2023年に2億4,221万米ドルと評価され、2024年には2億5,655万米ドルに達すると予測され、CAGR 6.44%で成長し、2030年には3億7,515万米ドルに達すると予測されています。

血液温度インジケータ（BTI）は、血液や血液製剤の温度をモニタリングするために設計された重要な装置であり、血液や血液製剤の収集、保管、輸送、輸血を通して、それらが望ましい温度範囲内に保たれることを保証します。これは、細菌汚染を防ぎ、血液製剤の有効性を確保するために必要です。BTIの適用範囲は医療施設、血液バンク、検査室を含み、そこではBTIは健康基準と患者安全プロトコルの遵守に不可欠です。BTIの必要性は、医療サービスの向上に対する需要の増加、厳しい規制、輸血関連感染に対する意識の高まりによって裏付けられています。BTIの市場は、技術の進歩、輸血を必要とする慢性疾患の罹患率の上昇、高齢者の拡大などの要因によって牽引されています。特に、医療インフラが急速に拡大している新興国市場開拓に機会があり、有望な市場ポテンシャルを示唆しています。革新的な研究開発セグメントとしては、非侵襲的BTI技術の開発、センサー精度の向上、デジタルヘルスプラットフォームとの統合、コスト効率の高い製造プロセスなどが挙げられます。しかし、先進的なBTIに関連する高コスト、未発達地域における認知度の低さ、既存の医療ITシステムとの統合における課題などの課題に市場は直面しています。また、製品承認や市場参入を遅らせる規制上のハードルも限界のひとつです。これらの課題に対処するため、企業はデジタルカルテとシームレスに統合し、品質を損なうことなく手頃な価格を実現する汎用性の高いBTIの設計に注力すべきです。医療ITプロバイダーとのコラボレーションや、シームレスな製品サポートの保証は、市場浸透をさらに促進します。BTI市場の性質は競争であり、大手企業はより大きなシェアを獲得するために研究開発に多額の投資を行っています。成長のための最良の戦略には、パートナーシップの育成、新興市場の対象化、世界の医療基準を満たすための規制変更への継続的な対応が含まれます。

市場力学：急速に進化する血液温度インジケータ市場の主要市場洞察を公開

血液温度インジケータ市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 手術件数の増加と安全な輸血の必要性
  • 安全な血液保管と輸送に関する医療規制の義務化
• 市場抑制要因
  • リコールリスクの可能性
• 市場機会
  • 先進的センサーとIoT機能の統合
  • 血液バンクの増加
• 市場課題
  • ユーザーエラーとシングルユース機器の安全な使い捨て

ポーターのファイブフォース：血液温度インジケータ市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：血液温度インジケータ市場における外部からの影響の把握

外部マクロ環境要因は、血液温度インジケータ市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：血液温度インジケータ市場における競合情勢の把握

血液温度インジケータ市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：血液温度インジケータ市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、血液温度インジケータ市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：血液温度インジケータ市場における成功への道筋を描く

血液温度インジケータ市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 手術件数の増加と安全な輸血の必要性
    • 血液の安全な保管と輸送に関する政府の医療規制義務
  • 抑制要因
    • リコールの恐れあり
  • 機会
    • 先進的センサーとIoT機能の統合
    • 血液バンクの増加
  • 課題
    • ユーザーのエラーと使い捨てデバイスの安全な廃棄
• 市場セグメンテーション分析
  • 温度範囲：全血や赤血球を保存するための2℃～4℃の範囲の適応性により、それらの機能を維持し、腐敗を防ぐことができる
  • 用途：医療施設におけるストレージモニタリングにおける血液温度インジケータの使用の拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 血液温度インジケータ市場：温度範囲別

• イントロダクション
• 2～4℃
• 5～7℃
• 7℃以上
• 2℃以下

第7章 血液温度インジケータ市場：用途別

• イントロダクション
• 保管モニタリング
• 輸送モニタリング

第8章 血液温度インジケータ市場：エンドユーザー別

• イントロダクション
• 血液バンク
• 病院・クリニック
• 研究機関

第9章 南北アメリカの血液温度インジケータ市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋の血液温度インジケータ市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの血液温度インジケータ市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • SpotSeeのTempMonitorの発売：医薬品保管における患者の安全性を革新
  • Dakota Integrated Solutions Ltd、Zebra Technologiesの革新的な血液温度計の英国主要サプライヤーに任命
• 戦略分析と提言

企業一覧

• 3M Company
• DeltaTrak Inc.
• Elitech
• Ellab Group
• Hanwell Solutions Ltd.
• Kentec Medical
• Lisaline Lifesciences Technologies
• Marketlab
• Sercalia, S.L.
• SpotSee
• Stream Peak International PTE Ltd
• Temptime Corporation
• Thermo Fisher Scientific Inc.
• TimeStrip UK Ltd
• Zebra Technologies Corporation

LIST OF FIGURES

• FIGURE 1. BLOOD TEMPERATURE INDICATOR MARKET RESEARCH PROCESS
• FIGURE 2. BLOOD TEMPERATURE INDICATOR MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BLOOD TEMPERATURE INDICATOR MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. BLOOD TEMPERATURE INDICATOR MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. BLOOD TEMPERATURE INDICATOR MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BLOOD TEMPERATURE INDICATOR MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BLOOD TEMPERATURE INDICATOR MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BLOOD TEMPERATURE INDICATOR MARKET DYNAMICS
• TABLE 7. GLOBAL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY 2°C TO 4°C, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY 5°C TO 7°C, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY ABOVE 7°C, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY UP TO 2°C, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY STORAGE MONITORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TRANSIT MONITORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. CANADA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 30. CANADA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. CANADA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. CHINA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 47. CHINA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. CHINA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. INDIA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 50. INDIA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. INDIA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. ITALY BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 102. ITALY BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. ITALY BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. POLAND BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 114. POLAND BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. POLAND BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. QATAR BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 117. QATAR BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. QATAR BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY TEMPERATURE RANGE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM BLOOD TEMPERATURE INDICATOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. BLOOD TEMPERATURE INDICATOR MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. BLOOD TEMPERATURE INDICATOR MARKET, FPNV POSITIONING MATRIX, 2023

The Blood Temperature Indicator Market was valued at USD 242.21 million in 2023, expected to reach USD 256.55 million in 2024, and is projected to grow at a CAGR of 6.44%, to USD 375.15 million by 2030.

Blood Temperature Indicators (BTIs) are critical devices designed to monitor the temperature of blood or blood products, ensuring they remain within the desired temperature range throughout collection, storage, transportation, and transfusion. This is necessary to prevent bacterial contamination and ensure the efficacy of blood products. The scope of BTIs encompasses healthcare facilities, blood banks, and laboratories, where they are integral in compliance with health standards and patient safety protocols. The necessity of BTIs is underscored by the increasing demand for improved healthcare services, stringent regulations, and growing awareness about transfusion-related infections. The market for BTIs is driven by factors such as technological advancements, rising incidence of chronic diseases requiring transfusions, and an expanding geriatric population. Opportunities arise particularly in developing regions where healthcare infrastructure is expanding rapidly, suggesting a promising market potential. Innovative areas of research include the development of non-invasive BTI technologies, enhancement of sensor accuracy, integration with digital health platforms, and cost-effective manufacturing processes. However, the market faces challenges such as high costs associated with advanced BTIs, limited awareness in underdeveloped regions, and challenges in integrating these devices with existing healthcare IT systems. Another limitation is the regulatory hurdles that can delay product approval and market entry. To address these challenges, businesses should focus on designing versatile BTIs that integrate seamlessly with digital health records and offer affordability without compromising quality. Collaborations with healthcare IT providers and assurances of seamless product support can further enhance market penetration. The nature of the BTI market is competitive, with major players investing heavily in R&D to capture a larger share. The best strategies for growth include fostering partnerships, targeting emerging markets, and continuously adapting to regulatory changes to meet global health standards.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Temperature Indicator Market

The Blood Temperature Indicator Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing number of surgeries and need for safe transfusion
  • Governmental healthcare regulatory mandates regarding safe blood storage and transportation
• Market Restraints
  • Possible risk of recall
• Market Opportunities
  • Integration of advanced sensors and IoT capabilities
  • Increasing number of blood banks
• Market Challenges
  • User errors and safe disposable of single-use devices

Porter's Five Forces: A Strategic Tool for Navigating the Blood Temperature Indicator Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Temperature Indicator Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Temperature Indicator Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Temperature Indicator Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Temperature Indicator Market

A detailed market share analysis in the Blood Temperature Indicator Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Temperature Indicator Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Temperature Indicator Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Temperature Indicator Market

A strategic analysis of the Blood Temperature Indicator Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Temperature Indicator Market, highlighting leading vendors and their innovative profiles. These include 3M Company, DeltaTrak Inc., Elitech, Ellab Group, Hanwell Solutions Ltd.,, Kentec Medical, Lisaline Lifesciences Technologies, Marketlab, Sercalia, S.L., SpotSee, Stream Peak International PTE Ltd, Temptime Corporation, Thermo Fisher Scientific Inc., TimeStrip UK Ltd, and Zebra Technologies Corporation.

Market Segmentation & Coverage

This research report categorizes the Blood Temperature Indicator Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Temperature Range, market is studied across 2°C to 4°C, 5°C to 7°C, Above 7°C, and Up to 2°C.
• Based on Application, market is studied across Storage Monitoring and Transit Monitoring.
• Based on End-User, market is studied across Blood Banks, Hospitals & Clinics, and Research Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing number of surgeries and need for safe transfusion
    • 5.1.1.2. Governmental healthcare regulatory mandates regarding safe blood storage and transportation
  • 5.1.2. Restraints
    • 5.1.2.1. Possible risk of recall
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of advanced sensors and IoT capabilities
    • 5.1.3.2. Increasing number of blood banks
  • 5.1.4. Challenges
    • 5.1.4.1. User errors and safe disposable of single-use devices
• 5.2. Market Segmentation Analysis
  • 5.2.1. Temperature Range: Adaptability of 2°C to 4°C range for storing whole blood and red blood cells helps preserve their function and prevents spoilage
  • 5.2.2. Application: Proliferation of use of blood temperature indicator from healthcare facilities in storage monitoring
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Blood Temperature Indicator Market, by Temperature Range

• 6.1. Introduction
• 6.2. 2°C to 4°C
• 6.3. 5°C to 7°C
• 6.4. Above 7°C
• 6.5. Up to 2°C

7. Blood Temperature Indicator Market, by Application

• 7.1. Introduction
• 7.2. Storage Monitoring
• 7.3. Transit Monitoring

8. Blood Temperature Indicator Market, by End-User

• 8.1. Introduction
• 8.2. Blood Banks
• 8.3. Hospitals & Clinics
• 8.4. Research Institutes

9. Americas Blood Temperature Indicator Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Blood Temperature Indicator Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Blood Temperature Indicator Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Launch of SpotSee's TempMonitor: Innovating Patient Safety in Medication Storage
  • 12.3.2. Dakota Integrated Solutions Ltd Appointed as a Key UK Supplier of Zebra Technologies' Innovative Blood Temperature Indicators
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Company
• 2. DeltaTrak Inc.
• 3. Elitech
• 4. Ellab Group
• 5. Hanwell Solutions Ltd.,
• 6. Kentec Medical
• 7. Lisaline Lifesciences Technologies
• 8. Marketlab
• 9. Sercalia, S.L.
• 10. SpotSee
• 11. Stream Peak International PTE Ltd
• 12. Temptime Corporation
• 13. Thermo Fisher Scientific Inc.
• 14. TimeStrip UK Ltd
• 15. Zebra Technologies Corporation